Cargando…
Combining tau-PET and fMRI meta-analyses for patient-centered prediction of cognitive decline in Alzheimer’s disease
BACKGROUND: Tau-PET is a prognostic marker for cognitive decline in Alzheimer’s disease, and the heterogeneity of tau-PET patterns matches cognitive symptom heterogeneity. Thus, tau-PET may allow precision-medicine prediction of individual tau-related cognitive trajectories, which can be important f...
Autores principales: | Biel, Davina, Luan, Ying, Brendel, Matthias, Hager, Paul, Dewenter, Anna, Moscoso, Alexis, Otero Svaldi, Diana, Higgins, Ixavier A., Pontecorvo, Michael, Römer, Sebastian, Steward, Anna, Rubinski, Anna, Zheng, Lukai, Schöll, Michael, Shcherbinin, Sergey, Ewers, Michael, Franzmeier, Nicolai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9639286/ https://www.ncbi.nlm.nih.gov/pubmed/36345046 http://dx.doi.org/10.1186/s13195-022-01105-5 |
Ejemplares similares
-
sTREM2 is associated with amyloid‐related p‐tau increases and glucose hypermetabolism in Alzheimer's disease
por: Biel, Davina, et al.
Publicado: (2023) -
Earlier Alzheimer’s disease onset is associated with tau pathology in brain hub regions and facilitated tau spreading
por: Frontzkowski, Lukas, et al.
Publicado: (2022) -
Tau-PET and in vivo Braak-staging as prognostic markers of future cognitive decline in cognitively normal to demented individuals
por: Biel, Davina, et al.
Publicado: (2021) -
The BIN1 rs744373 SNP is associated with increased tau-PET levels and impaired memory
por: Franzmeier, Nicolai, et al.
Publicado: (2019) -
FDG-PET hypermetabolism is associated with higher tau-PET in mild cognitive impairment at low amyloid-PET levels
por: Rubinski, Anna, et al.
Publicado: (2020)